Rallybio Corp (RLYB) SEC Filings — 2024
17 SEC filings for Rallybio Corp (RLYB) in 2024.
Filings
- Rallybio Corp SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Rallybio Corp Q3 2024: Zero Revenue Continues — 10-Q · Nov 7, 2024
- Rallybio Names New Chief Medical Officer — 8-K · Sep 17, 2024
- Rallybio Corp Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
- Rallybio Corp SC 13G/A Filing — SC 13G/A · Jul 30, 2024
- Rallybio Corp SC 13G Filing — SC 13G · Jul 30, 2024
- Rallybio Corp Files 8-K on Executive and Board Changes — 8-K · Jul 23, 2024
- Rallybio Corp Files 8-K on Shareholder Matters — 8-K · May 21, 2024
- Rallybio Corp Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Rallybio Corp. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 11, 2024
- Rallybio Corp Files 8-K: Material Agreement & Equity Sales — 8-K · Apr 10, 2024
- Rallybio Corp Files 2023 Annual Report on Form 10-K — 10-K · Mar 12, 2024
- Rallybio Corp SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Pivotal bioVenture Partners Amends Rallybio Stake on Feb 12 — SC 13D/A · Feb 12, 2024
- FMR LLC & Abigail Johnson Report 6.708% Stake in Rallybio Corp — SC 13G/A · Feb 9, 2024
- Rallybio Files 8-K on Operations, Exit Costs — 8-K · Feb 6, 2024
- Novo Holdings A/S Maintains 1.76M Share Stake in Rallybio Corp — SC 13G/A · Jan 2, 2024